nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—Erythema—Bleomycin—testicular cancer	0.00282	0.00282	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Gentamicin—Hallucination—Ifosfamide—testicular cancer	0.00276	0.00276	CcSEcCtD
Gentamicin—Alopecia—Dactinomycin—testicular cancer	0.00267	0.00267	CcSEcCtD
Gentamicin—Thrombocytopenia—Vinblastine—testicular cancer	0.00267	0.00267	CcSEcCtD
Gentamicin—Visual impairment—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—testicular cancer	0.00265	0.00265	CcSEcCtD
Gentamicin—Erythema—Dactinomycin—testicular cancer	0.00263	0.00263	CcSEcCtD
Gentamicin—Anaemia—Bleomycin—testicular cancer	0.00261	0.00261	CcSEcCtD
Gentamicin—Neuropathy peripheral—Cisplatin—testicular cancer	0.00261	0.00261	CcSEcCtD
Gentamicin—Stomatitis—Cisplatin—testicular cancer	0.0026	0.0026	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Gentamicin—Decreased appetite—Chlorambucil—testicular cancer	0.00259	0.00259	CcSEcCtD
Gentamicin—Tinnitus—Ifosfamide—testicular cancer	0.00259	0.00259	CcSEcCtD
Gentamicin—Leukopenia—Bleomycin—testicular cancer	0.00253	0.00253	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Feeling abnormal—Chlorambucil—testicular cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Paraesthesia—Vinblastine—testicular cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Alopecia—Ifosfamide—testicular cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Anaemia—Dactinomycin—testicular cancer	0.00244	0.00244	CcSEcCtD
Gentamicin—Erythema—Ifosfamide—testicular cancer	0.00241	0.00241	CcSEcCtD
Gentamicin—Neuropathy peripheral—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Gentamicin—Stomatitis—Etoposide—testicular cancer	0.00238	0.00238	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Gentamicin—Decreased appetite—Vinblastine—testicular cancer	0.00237	0.00237	CcSEcCtD
Gentamicin—Urticaria—Chlorambucil—testicular cancer	0.00237	0.00237	CcSEcCtD
Gentamicin—Leukopenia—Dactinomycin—testicular cancer	0.00236	0.00236	CcSEcCtD
Gentamicin—Body temperature increased—Chlorambucil—testicular cancer	0.00235	0.00235	CcSEcCtD
Gentamicin—Confusional state—Bleomycin—testicular cancer	0.00232	0.00232	CcSEcCtD
Gentamicin—Anaphylactic shock—Bleomycin—testicular cancer	0.00231	0.00231	CcSEcCtD
Gentamicin—Visual impairment—Cisplatin—testicular cancer	0.0023	0.0023	CcSEcCtD
Gentamicin—Agranulocytosis—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Gentamicin—Thrombocytopenia—Bleomycin—testicular cancer	0.00226	0.00226	CcSEcCtD
Gentamicin—Feeling abnormal—Vinblastine—testicular cancer	0.00225	0.00225	CcSEcCtD
Gentamicin—Anaemia—Ifosfamide—testicular cancer	0.00223	0.00223	CcSEcCtD
Gentamicin—Tinnitus—Cisplatin—testicular cancer	0.00223	0.00223	CcSEcCtD
Gentamicin—Salivary hypersecretion—Doxorubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Gentamicin—Hypersensitivity—Chlorambucil—testicular cancer	0.00219	0.00219	CcSEcCtD
Gentamicin—Hypoaesthesia—Etoposide—testicular cancer	0.00218	0.00218	CcSEcCtD
Gentamicin—Vertigo—Ifosfamide—testicular cancer	0.00217	0.00217	CcSEcCtD
Gentamicin—Leukopenia—Ifosfamide—testicular cancer	0.00216	0.00216	CcSEcCtD
Gentamicin—Hypotension—Bleomycin—testicular cancer	0.00215	0.00215	CcSEcCtD
Gentamicin—Alopecia—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Gentamicin—Pruritus—Chlorambucil—testicular cancer	0.00211	0.00211	CcSEcCtD
Gentamicin—Thrombocytopenia—Dactinomycin—testicular cancer	0.00211	0.00211	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.0021	0.0021	CcSEcCtD
Gentamicin—Convulsion—Ifosfamide—testicular cancer	0.00209	0.00209	CcSEcCtD
Gentamicin—Hypertension—Ifosfamide—testicular cancer	0.00208	0.00208	CcSEcCtD
Gentamicin—Erythema—Cisplatin—testicular cancer	0.00208	0.00208	CcSEcCtD
Gentamicin—Paraesthesia—Bleomycin—testicular cancer	0.00207	0.00207	CcSEcCtD
Gentamicin—Phlebitis—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Gentamicin—Arthralgia—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Gentamicin—Hypersensitivity—Vinblastine—testicular cancer	0.00201	0.00201	CcSEcCtD
Gentamicin—Decreased appetite—Bleomycin—testicular cancer	0.002	0.002	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—testicular cancer	0.002	0.002	CcSEcCtD
Gentamicin—Confusional state—Ifosfamide—testicular cancer	0.00199	0.00199	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Gentamicin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00197	0.00197	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00196	0.00196	CcSEcCtD
Gentamicin—Alopecia—Etoposide—testicular cancer	0.00194	0.00194	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—testicular cancer	0.00194	0.00194	CcSEcCtD
Gentamicin—Thrombocytopenia—Ifosfamide—testicular cancer	0.00193	0.00193	CcSEcCtD
Gentamicin—Anaemia—Cisplatin—testicular cancer	0.00192	0.00192	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—testicular cancer	0.00191	0.00191	CcSEcCtD
Gentamicin—Feeling abnormal—Bleomycin—testicular cancer	0.0019	0.0019	CcSEcCtD
Gentamicin—Vomiting—Chlorambucil—testicular cancer	0.00189	0.00189	CcSEcCtD
Gentamicin—Decreased appetite—Dactinomycin—testicular cancer	0.00187	0.00187	CcSEcCtD
Gentamicin—Leukopenia—Cisplatin—testicular cancer	0.00186	0.00186	CcSEcCtD
Gentamicin—Purpura—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Gentamicin—Hypotension—Ifosfamide—testicular cancer	0.00184	0.00184	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Gentamicin—Urticaria—Bleomycin—testicular cancer	0.00183	0.00183	CcSEcCtD
Gentamicin—Body temperature increased—Bleomycin—testicular cancer	0.00182	0.00182	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Gentamicin—Dizziness—Vinblastine—testicular cancer	0.00181	0.00181	CcSEcCtD
Gentamicin—Convulsion—Cisplatin—testicular cancer	0.0018	0.0018	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Gentamicin—Feeling abnormal—Dactinomycin—testicular cancer	0.00177	0.00177	CcSEcCtD
Gentamicin—Nausea—Chlorambucil—testicular cancer	0.00177	0.00177	CcSEcCtD
Gentamicin—Paraesthesia—Ifosfamide—testicular cancer	0.00177	0.00177	CcSEcCtD
Gentamicin—Anaemia—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Gentamicin—Vomiting—Vinblastine—testicular cancer	0.00174	0.00174	CcSEcCtD
Gentamicin—Vertigo—Etoposide—testicular cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Decreased appetite—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Headache—Vinblastine—testicular cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—testicular cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gentamicin—Body temperature increased—Dactinomycin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gentamicin—Anaphylactic shock—Cisplatin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gentamicin—Hypersensitivity—Bleomycin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Gentamicin—Thrombocytopenia—Cisplatin—testicular cancer	0.00166	0.00166	CcSEcCtD
Gentamicin—Convulsion—Etoposide—testicular cancer	0.00165	0.00165	CcSEcCtD
Gentamicin—Hypertension—Etoposide—testicular cancer	0.00165	0.00165	CcSEcCtD
Gentamicin—Pruritus—Bleomycin—testicular cancer	0.00163	0.00163	CcSEcCtD
Gentamicin—Feeling abnormal—Ifosfamide—testicular cancer	0.00162	0.00162	CcSEcCtD
Gentamicin—Eosinophilia—Methotrexate—testicular cancer	0.00162	0.00162	CcSEcCtD
Gentamicin—Nausea—Vinblastine—testicular cancer	0.00162	0.00162	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Gentamicin—Hypotension—Cisplatin—testicular cancer	0.00159	0.00159	CcSEcCtD
Gentamicin—Hypersensitivity—Dactinomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Gentamicin—Confusional state—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Gentamicin—Urticaria—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Gentamicin—Body temperature increased—Ifosfamide—testicular cancer	0.00156	0.00156	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Gentamicin—Paraesthesia—Cisplatin—testicular cancer	0.00153	0.00153	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Gentamicin—Decreased appetite—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Gentamicin—Vomiting—Bleomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Gentamicin—Hypotension—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Gentamicin—Rash—Bleomycin—testicular cancer	0.00145	0.00145	CcSEcCtD
Gentamicin—Dermatitis—Bleomycin—testicular cancer	0.00145	0.00145	CcSEcCtD
Gentamicin—Hypersensitivity—Ifosfamide—testicular cancer	0.00145	0.00145	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Gentamicin—Feeling abnormal—Cisplatin—testicular cancer	0.0014	0.0014	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Gentamicin—Pruritus—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Gentamicin—Nausea—Bleomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Gentamicin—Vomiting—Dactinomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Gentamicin—Rash—Dactinomycin—testicular cancer	0.00136	0.00136	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Gentamicin—Body temperature increased—Cisplatin—testicular cancer	0.00134	0.00134	CcSEcCtD
Gentamicin—Neuropathy peripheral—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Gentamicin—Stomatitis—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Gentamicin—Dizziness—Ifosfamide—testicular cancer	0.0013	0.0013	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Gentamicin—Nausea—Dactinomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Gentamicin—Vomiting—Ifosfamide—testicular cancer	0.00125	0.00125	CcSEcCtD
Gentamicin—Hypersensitivity—Cisplatin—testicular cancer	0.00125	0.00125	CcSEcCtD
Gentamicin—Rash—Ifosfamide—testicular cancer	0.00124	0.00124	CcSEcCtD
Gentamicin—Dermatitis—Ifosfamide—testicular cancer	0.00124	0.00124	CcSEcCtD
Gentamicin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Gentamicin—Urticaria—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Gentamicin—Nausea—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—testicular cancer	0.00115	0.00115	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gentamicin—Erythema—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Gentamicin—Pruritus—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gentamicin—Vomiting—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gentamicin—Rash—Cisplatin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gentamicin—Dermatitis—Cisplatin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gentamicin—Erythema—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Gentamicin—Anaemia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Gentamicin—Dizziness—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Gentamicin—Nausea—Cisplatin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—testicular cancer	0.00099	0.00099	CcSEcCtD
Gentamicin—Vomiting—Etoposide—testicular cancer	0.000989	0.000989	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Gentamicin—Rash—Etoposide—testicular cancer	0.000981	0.000981	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—testicular cancer	0.00098	0.00098	CcSEcCtD
Gentamicin—Headache—Etoposide—testicular cancer	0.000975	0.000975	CcSEcCtD
Gentamicin—Arthralgia—Methotrexate—testicular cancer	0.000972	0.000972	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—testicular cancer	0.00096	0.00096	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Gentamicin—Confusional state—Methotrexate—testicular cancer	0.00094	0.00094	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—testicular cancer	0.000932	0.000932	CcSEcCtD
Gentamicin—Convulsion—Epirubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Gentamicin—Nausea—Etoposide—testicular cancer	0.000924	0.000924	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—testicular cancer	0.000923	0.000923	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—testicular cancer	0.000913	0.000913	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—testicular cancer	0.00091	0.00091	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—testicular cancer	0.000889	0.000889	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—testicular cancer	0.000885	0.000885	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—testicular cancer	0.00088	0.00088	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—testicular cancer	0.000872	0.000872	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—testicular cancer	0.000871	0.000871	CcSEcCtD
Gentamicin—Convulsion—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000849	0.000849	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—testicular cancer	0.000842	0.000842	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—testicular cancer	0.000837	0.000837	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—testicular cancer	0.000815	0.000815	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—testicular cancer	0.000814	0.000814	CcSEcCtD
Gentamicin—Decreased appetite—Methotrexate—testicular cancer	0.00081	0.00081	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—testicular cancer	0.00079	0.00079	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Gentamicin—Feeling abnormal—Methotrexate—testicular cancer	0.000768	0.000768	CcSEcCtD
Gentamicin—Decreased appetite—Epirubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Gentamicin—Urticaria—Methotrexate—testicular cancer	0.000741	0.000741	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—testicular cancer	0.000737	0.000737	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000735	0.000735	CcSEcCtD
Gentamicin—Paraesthesia—Doxorubicin—testicular cancer	0.000725	0.000725	CcSEcCtD
Gentamicin—Feeling abnormal—Epirubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Gentamicin—Decreased appetite—Doxorubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Gentamicin—Urticaria—Epirubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—testicular cancer	0.00069	0.00069	CcSEcCtD
Gentamicin—Hypersensitivity—Methotrexate—testicular cancer	0.000687	0.000687	CcSEcCtD
Gentamicin—Feeling abnormal—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—testicular cancer	0.000659	0.000659	CcSEcCtD
Gentamicin—Hypersensitivity—Epirubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—testicular cancer	0.000638	0.000638	CcSEcCtD
Gentamicin—Pruritus—Epirubicin—testicular cancer	0.000617	0.000617	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—testicular cancer	0.000616	0.000616	CcSEcCtD
Gentamicin—Hypersensitivity—Doxorubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—testicular cancer	0.000593	0.000593	CcSEcCtD
Gentamicin—Rash—Methotrexate—testicular cancer	0.000588	0.000588	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—testicular cancer	0.000587	0.000587	CcSEcCtD
Gentamicin—Headache—Methotrexate—testicular cancer	0.000584	0.000584	CcSEcCtD
Gentamicin—Dizziness—Epirubicin—testicular cancer	0.000577	0.000577	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—testicular cancer	0.000571	0.000571	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Gentamicin—Nausea—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Gentamicin—Rash—Epirubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Gentamicin—Headache—Epirubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Gentamicin—Dizziness—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Gentamicin—Nausea—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Gentamicin—Rash—Doxorubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Gentamicin—Headache—Doxorubicin—testicular cancer	0.000506	0.000506	CcSEcCtD
Gentamicin—Nausea—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
